BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 26184049)

  • 21. Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum.
    Jayes FL; Liu B; Moutos FT; Kuchibhatla M; Guilak F; Leppert PC
    Am J Obstet Gynecol; 2016 Nov; 215(5):596.e1-596.e8. PubMed ID: 27177523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of biomechanical and collagen heterogeneity in uterine fibroids.
    Jayes FL; Liu B; Feng L; Aviles-Espinoza N; Leikin S; Leppert PC
    PLoS One; 2019; 14(4):e0215646. PubMed ID: 31034494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine fibroid tumors: long-term MR imaging outcome after embolization.
    Pelage JP; Guaou NG; Jha RC; Ascher SM; Spies JB
    Radiology; 2004 Mar; 230(3):803-9. PubMed ID: 14990844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids.
    Brunengraber LN; Jayes FL; Leppert PC
    Reprod Sci; 2014 Dec; 21(12):1452-9. PubMed ID: 25332216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroids treated by uterine artery embolization. A review.
    Lund N; Justesen P; Elle B; Thomsen SG; Floridon C
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):905-10. PubMed ID: 11081668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic management of uterine fibroids.
    Agdi M; Tulandi T
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):707-16. PubMed ID: 18325839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis and pro-angiogenic factors in uterine fibroids - facts and myths.
    Konarska M; Wrona AN; Aleksandrovych V; Bereza T; Sajewicz M; Gach-Kuniewicz B; Lis M; Komnata K; Paziewski M; Maleszka A; Depukat P; Solewski B; Warchoł Ł
    Folia Med Cracov; 2016; 56(2):37-43. PubMed ID: 28013320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular density, angiogenesis and pro-angiogenic factors in uterine fibroids.
    Sajewicz M; Konarska M; Wrona AN; Aleksandrovych V; Bereza T; Komnata K; Solewski B; Maleszka A; Depukat P; Warchoł Ł
    Folia Med Cracov; 2016; 56(1):27-32. PubMed ID: 27513836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?
    Islam MS; Akhtar MM; Ciavattini A; Giannubilo SR; Protic O; Janjusevic M; Procopio AD; Segars JH; Castellucci M; Ciarmela P
    Mol Nutr Food Res; 2014 Aug; 58(8):1667-84. PubMed ID: 24976593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular biology of uterine fibroids: connecting fibroids and vascular disorders.
    Kirschen GW; AlAshqar A; Miyashita-Ishiwata M; Reschke L; El Sabeh M; Borahay MA
    Reproduction; 2021 Jul; 162(2):R1-R18. PubMed ID: 34034234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophages and Immune Responses in Uterine Fibroids.
    Zannotti A; Greco S; Pellegrino P; Giantomassi F; Delli Carpini G; Goteri G; Ciavattini A; Ciarmela P
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?
    Böckelmann LC; Schumacher U
    Expert Opin Ther Targets; 2019 Dec; 23(12):1005-1014. PubMed ID: 31825703
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications.
    AlAshqar A; Lulseged B; Mason-Otey A; Liang J; Begum UAM; Afrin S; Borahay MA
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The extracellular matrix contributes to mechanotransduction in uterine fibroids.
    Leppert PC; Jayes FL; Segars JH
    Obstet Gynecol Int; 2014; 2014():783289. PubMed ID: 25110476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine perfusion model for analyzing barriers to transport in fibroids.
    Stirland DL; Nichols JW; Jarboe E; Adelman M; Dassel M; Janát-Amsbury MM; Bae YH
    J Control Release; 2015 Sep; 214():85-93. PubMed ID: 26184049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.
    Tal R; Segars JH
    Hum Reprod Update; 2014; 20(2):194-216. PubMed ID: 24077979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.